Terms: = Head and neck cancer AND RAP1GDS1, P52306, 5910, MGC118861, MGC118859, GDS1, ENSG00000138698 AND Treatment
2 results:
1. A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinoma.
Li N; Wu T; Hong YG; Guo YZ; Cheng YF; Ma YJ; Bie LY; Cui DH; Gao XH; Tan BX; Li BS; Luo SX; Wang JS
BMC Med; 2022 Dec; 20(1):472. PubMed ID: 36482345
[TBL] [Abstract] [Full Text] [Related]
2. Results of sequential swallowing assessments in patients undergoing upfront surgery for oral tongue squamous cell carcinoma.
Sawhney S; Thiagarajan S; Balaji A; Sathe P; Jain S; Rukmangathan TM; Kannan S; Shah S; Chaukar D
Oral Oncol; 2022 Feb; 125():105684. PubMed ID: 34963096
[TBL] [Abstract] [Full Text] [Related]
